Search

everythinglearnresearchcommunity

for

Search:↓

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

The research helps understand how finasteride works and aids drug development.

Low-dose isotretinoin is as effective as conventional doses for acne and has fewer side effects.

A 6-year-old boy's skin condition improved after stopping a specific treatment and starting new medications.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The CRABP I gene in cashmere goats is highly conserved but has unique features at specific amino sites.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

DPR can show different hair characteristics, as seen in two brothers with normal hair.

Evidence-based medicine needs improvement to better tailor treatments to individual patients.

ROR2 is crucial for hair follicle stem cell maintenance and self-renewal.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Contact immunotherapy helped hair regrow in a patient with both alopecia and psoriasis.